glp-1 drinkable Danone launches Oikos yogurt drink aimed at users Understanding GLP-1: What You Need
Description
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
R.QuarantaV.et al (2016)
They mimic natural hormones to regulate hunger, blood sugar, and digestion, supporting lasting progress when paired with real care
Houston BT et al
10.3727/096368914x678508 [DOI] [PubMed] [Google Scholar] DellaValle B., Brix G
